Clinical Trial Update: Controlled Trial of Omadacycline Randomized Treatment Given for Bone and Joint Infection [Phase 2]

View source ↗

Summary

This Phase 2 randomized trial assesses omadacycline for bone and joint infections; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteomyelitis
• Septic Arthritis

Drugs mentioned

• Nuzyra (Omadacycline)

Snippet

Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | Conditions: Bone Infection, Joint Infection | Phase 2 | Status: ACTIVE_NOT_RECRUITING